Oil rises on tight inventories

Must Read

OilNOW
OilNOW
OilNOW is an online-based Information and Resource Centre
- ADVERTISEMENT -

(Reuters) – Oil prices rose on Tuesday, supported by the prospect of tight inventories across the globe, although the gains were capped by forecasts of an increase in global production in coming months and concerns over rising coronavirus cases in Europe.

Brent crude was 52 cents, or 0.6%, higher at $82.57 a barrel, by 1110 GMT, and U.S. West Texas Intermediate (WTI) crude climbed 42 cents, or 0.5%, to $81.30 a barrel.

“The oil market will remain tight in the short term, which should lend support to prices,” said Commerzbank analyst Carsten Fritsch.

Trafigura’s Chief Executive Officer Jeremy Weir said the tightness in global oil markets was due to return of demand to pre-pandemic levels.

“It’s not artificially tight because of what OPEC is doing. Demand is there,” Weir said at the FT Commodities Asia Summit.

However, the International Energy Agency (IEA) said the oil market rally may ease off as high prices could provide a strong incentive to boost production, particularly in the United States.

The IEA said it expected average Brent prices to be around $71.50 per barrel in 2021 and $79.40 in 2022.

OPEC Secretary General Mohammad Barkindo also said on Tuesday that he expects an oil supply surplus as early as December and the market to remain oversupplied next year.

“The surplus is already beginning in December. These are signals that we have to be very, very careful,” he said.

The Organization of the Petroleum Exporting Countries (OPEC) last week cut its world oil demand forecast for the fourth quarter by 330,000 barrels per day (bpd) from last month’s forecast, as high energy prices hampered economic recovery from the COVID-19 pandemic.

Still, worries about demand destruction due to the COVID-19 pandemic weighed.

Europe has again become the epicentre of the COVID-19 pandemic, prompting some governments to consider re-imposing lockdowns, while China is battling the spread of its biggest outbreak caused by the Delta variant.

- Advertisement -
spot_img

Latest News

Innate Pharma Announces Its Participation to Upcoming Investor Conference

MARSEILLE, France--(BUSINESS WIRE)--#ANKET--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that members...

More Articles Like This